All Biotech News

List of articles in category All Biotech News
Title	Published Date
Agendia Appoints Patrick J. Balthrop Sr., Former CEO of Luminex, as Chairman	04/12/2017
LDC and SOTIO Enter License and Collaboration Agreement for First-in-class Cancer Metabolism Program	04/11/2017
LifeCodexx and Charité to Form Research Alliance Following Successful Clinical Proof-Of Principle for Molecular Genetic-Based Preeclampsia Assay	04/11/2017
Asceneuron Receives Regulatory Approval for Phase I Healthy Volunteer Study of Oral Tau Inhibitor	04/06/2017
RedHill Biopharma Announces Exclusive U.S. License from Entera Health for Commercial GI Product EnteraGam®	04/05/2017
RedHill Biopharma Receives FDA Orphan Drug Designation for YELIVA® for the Treatment of Cholangiocarcinoma	04/04/2017
NBE-Therapeutics Expands Board of Directors by the Appointment of Hans-Peter Gerber	04/04/2017
Australia’s Bionic Vision Technologies Raises USD18 Million (AUD23.5 M) to Develop ‘Bionic Eye’ for Global Markets	04/03/2017
Imanova Receives £1M Award from the MRC To Develop Early Markers of Dementia – the MIND-MAPS Study	04/03/2017
Calypso Biotech Licenses CALY-001 Best-In-Class Anti-MMP-9 Antibody to EA Pharma	03/31/2017
Vetter’s Dr. Claudia Roth is Appointed to the Fraunhofer Advisory Board	03/28/2017
Selvita and Menarini Group Announce Global License Agreement for Clinical Stage Oncology Drug PIM/FLT3 Inhibitor SEL24	03/28/2017
Chemotherapy as a Tablet Instead of an Intravenous Infusion: A Benefit for the Patient	03/27/2017
RedHill Biopharma Announces First Patient Dosed in the Open-Label Extension Study to the Phase III Study with RHB-104 for Crohn’s Disease	03/21/2017
European Group on Tumour Markers (EGTM) Updated Guidelines Recommend Agendia’s MammaPrint® Test with Highest Level 1A Clinical Evidence	03/21/2017
Selvita Announces First Patient Dosed in Phase I/II Clinical Trial of SEL24 in Acute Myeloid Leukemia	03/17/2017
Genomic Health Unveils a Wealth of Data for the Oncotype DX® Breast Cancer Test, Reinforcing Its Value in Improving Patient Outcomes and Leading to More Cost-Effective Management	03/17/2017
Cambridge-based Astex Pharmaceuticals Celebrates as Cancer Drug Receives US Marketing Approval	03/13/2017
Selvita to Present New Data from its Oncology Programs at the Upcoming AACR Annual Meeting 2017	03/13/2017
German Community of Gynecological Oncology (AGO) Acknowledges MammaPrint in Breast Cancer Guidelines as Having Level 1A Clinical Evidence	03/08/2017
Dr Igor Matushansky Appointed Global Head, Research and Development of Hookipa Biotech	03/06/2017
Apollo Therapeutics: Funding of Four Initial Projects and Operational Update	02/22/2017
AmpTec and CMC Pharma Close Consulting Agreement about API-mRNA Production for IND/CTA Use in Early Phase Clinical Studies	02/21/2017
CellGenix Headquarters Expands to Meet the Increasing Demands for GMP Cell Culture Reagents	02/21/2017
Sartorius Enters Into a Corporate Partnership Program with the European Molecular Biology Laboratory (EMBL)	02/17/2017
Polyganics’ “STOP NEUROMA” Study Interim Data Shows Reduction in Pain	02/16/2017
MammaTyper® Enables More Precise Prediction of the Response to Neoadjuvant Chemotherapy Compared to Manual or Digitalized IHC	02/15/2017
RedHill Biopharma Announces Enrollment of Last Patient in BEKINDA® Phase III Study for Acute Gastroenteritis	02/13/2017
OrthoSera Closes Series B Financing Round	02/09/2017
Trod Medical Receives US Patent Allowance for Prostate Focal Therapy Encage™ Device	02/08/2017

Page 38 of 84